BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Herr DR, Chew WS, Satish RL, Ong WY. Pleotropic Roles of Autotaxin in the Nervous System Present Opportunities for the Development of Novel Therapeutics for Neurological Diseases. Mol Neurobiol 2020;57:372-92. [PMID: 31364025 DOI: 10.1007/s12035-019-01719-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Joshi L, Plastira I, Bernhart E, Reicher H, Koyani CN, Madl T, Madreiter-Sokolowski C, Koshenov Z, Graier WF, Hallström S, Sattler W. Lysophosphatidic Acid Induces Aerobic Glycolysis, Lipogenesis, and Increased Amino Acid Uptake in BV-2 Microglia. Int J Mol Sci 2021;22:1968. [PMID: 33671212 DOI: 10.3390/ijms22041968] [Reference Citation Analysis]
2 Uenaka M, Uyeda A, Nakahara T, Muramatsu R. LPA2 promotes neuronal differentiation and neurite formation in neocortical development. Biochemical and Biophysical Research Communications 2022;598:89-94. [DOI: 10.1016/j.bbrc.2022.01.109] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gento-Caro Á, Vilches-Herrando E, García-Morales V, Portillo F, Rodríguez-Bey G, González-Forero D, Moreno-López B. Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice. Neuropathol Appl Neurobiol 2021. [PMID: 33508894 DOI: 10.1111/nan.12699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Litchfield M, Wuest M, Glubrecht D, Briard E, Auberson YP, McMullen TPW, Brindley DN, Wuest F. Positron Emission Tomography Imaging of Autotaxin in Thyroid and Breast Cancer Models Using [18F]PRIMATX. Mol Pharm 2021;18:3352-64. [PMID: 34319110 DOI: 10.1021/acs.molpharmaceut.1c00265] [Reference Citation Analysis]
5 Kraemer MP, Mao G, Hammill C, Yan B, Li Y, Onono F, Smyth SS, Morris AJ. Effects of diet and hyperlipidemia on levels and distribution of circulating lysophosphatidic acid. J Lipid Res 2019;60:1818-28. [PMID: 31484695 DOI: 10.1194/jlr.M093096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
6 Wang J, Zhou D, Dai Z, Li X. Association Between Systemic Immune-Inflammation Index and Diabetic Depression. Clin Interv Aging 2021;16:97-105. [PMID: 33469277 DOI: 10.2147/CIA.S285000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Amaral RF, Geraldo LHM, Einicker-Lamas M, E Spohr TCLS, Mendes F, Lima FRS. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA1 receptor. J Neurochem 2021;156:499-512. [PMID: 32438456 DOI: 10.1111/jnc.15097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
8 García-Marchena N, Pizarro N, Pavón FJ, Martínez-Huélamo M, Flores-López M, Requena-Ocaña N, Araos P, Silva-Peña D, Suárez J, Santín LJ, de la Torre R, Rodríguez de Fonseca F, Serrano A. Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients. Sci Rep 2020;10:17163. [PMID: 33051508 DOI: 10.1038/s41598-020-74155-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Abdel-Magid AF. Therapeutic Potential of Autotaxin Inhibitors in Treatment of Interstitial Lung Diseases. ACS Med Chem Lett 2020;11:2075-6. [PMID: 33214812 DOI: 10.1021/acsmedchemlett.0c00467] [Reference Citation Analysis]
10 Hao Y, Guo M, Feng Y, Dong Q, Cui M. Lysophospholipids and Their G-Coupled Protein Signaling in Alzheimer's Disease: From Physiological Performance to Pathological Impairment. Front Mol Neurosci 2020;13:58. [PMID: 32351364 DOI: 10.3389/fnmol.2020.00058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Xiang H, Lu Y, Shao M, Wu T. Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases. J Cancer 2020;11:3519-35. [PMID: 32284748 DOI: 10.7150/jca.41841] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Langedijk JAGM, Beuers UH, Oude Elferink RPJ. Cholestasis-Associated Pruritus and Its Pruritogens. Front Med (Lausanne) 2021;8:639674. [PMID: 33791327 DOI: 10.3389/fmed.2021.639674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Geraldo LHM, Spohr TCLS, Amaral RFD, Fonseca ACCD, Garcia C, Mendes FA, Freitas C, dosSantos MF, Lima FRS. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Transduct Target Ther 2021;6:45. [PMID: 33526777 DOI: 10.1038/s41392-020-00367-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
14 Cho YJ, Choi SH, Lee RM, Cho HS, Rhim H, Kim HC, Kim BJ, Kim JH, Nah SY. Protective Effects of Gintonin on Reactive Oxygen Species-Induced HT22 Cell Damages: Involvement of LPA1 Receptor-BDNF-AKT Signaling Pathway. Molecules 2021;26:4138. [PMID: 34299412 DOI: 10.3390/molecules26144138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jia Y, Li Y, Xu XD, Tian Y, Shang H. Design and Development of Autotaxin Inhibitors. Pharmaceuticals (Basel) 2021;14:1203. [PMID: 34832985 DOI: 10.3390/ph14111203] [Reference Citation Analysis]
16 Birgbauer E. Lysophosphatidic Acid Signalling in Nervous System Development and Function. Neuromolecular Med 2021;23:68-85. [PMID: 33151452 DOI: 10.1007/s12017-020-08630-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ren J, Lin J, Yu L, Yan M. Lysophosphatidylcholine: Potential Target for the Treatment of Chronic Pain. IJMS 2022;23:8274. [DOI: 10.3390/ijms23158274] [Reference Citation Analysis]
18 Sun GY, Geng X, Teng T, Yang B, Appenteng MK, Greenlief CM, Lee JC. Dynamic Role of Phospholipases A2 in Health and Diseases in the Central Nervous System. Cells 2021;10:2963. [PMID: 34831185 DOI: 10.3390/cells10112963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Gento-Caro Á, Vilches-Herrando E, Portillo F, González-Forero D, Moreno-López B. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Brain Pathol 2021;:e13022. [PMID: 34585475 DOI: 10.1111/bpa.13022] [Reference Citation Analysis]